We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

BIO-RAD LABORATORIES

Provides full range of instrumentation, reagent kits, software and quality control systems to clinical laboratories. ... read more Featured Products: More products

Download Mobile App




Next Generation Cardiac Control Monitors Precision of Instrument Testing For Cardiac Events

By LabMedica International staff writers
Posted on 17 Apr 2023
Print article
Image: The new Cardiac Advance controls are optimized with Troponin targets near the limit of instrument detection (Photo courtesy of Bio-Rad)
Image: The new Cardiac Advance controls are optimized with Troponin targets near the limit of instrument detection (Photo courtesy of Bio-Rad)

Annually, approximately 17.9 million lives are lost to Cardiovascular Disease (CVD), accounting for nearly 32% of all global deaths and making CVD the leading cause of death worldwide. The World Health Organization states that 85% of these deaths result from heart attacks and strokes, with half of the victims dying before reaching the hospital. When patients experience chest pain, prompt detection and diagnosis are crucial for making critical treatment decisions. Diagnoses often depend on accurate assessments of specific cardiac markers, which hold significant importance for both patients and care providers in determining the appropriate treatment course. As a result, a generic control may not adequately monitor performance where laboratories need it most, making it essential to select quality control products aimed at medical decision levels suitable for the tested cardiac markers.

Bio-Rad Laboratories (Hercules, CA, USA) has introduced its latest cardiac control product, Cardiac Advance. This next-generation control is designed to monitor instrument testing precision for cardiac events and is optimized with Troponin I and T targets near the limit of instrument detection, in line with the latest guidelines established by the AACC and IFCC. Furthermore, Cardiac Advance control consolidates 10 of the most commonly tested cardiac analytes, such as Troponin, CK-MB, BNP/ProBNP, and Myoglobin.

Bio-Rad's Cardiac Advance control is available in multiple formats, including the standard Liquichek human serum-based control, as well as automation-ready InteliQ and compact vial configurations designed to streamline QC workflows, saving time and resources. Cardiac Advance controls are compatible with Siemens and Roche platforms and are accessible in the US, Europe, and selected Asian markets.

Related Links:
Bio-Rad Laboratories 

New
Gold Member
ANCA IFA
Kallestad Autoimmune ANCA IFA Complete Kit
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Stand-Alone Disc Remover
NS96
New
Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The Accelerate WAVE system delivers rapid AST directly from positive blood culture bottles (Photo courtesy of Accelerate Diagnostics)

Rapid Diagnostic System to Deliver Same-Shift Antibiotic Susceptibility Test Results

The World Health Organization estimates that sepsis impacts around 49 million people worldwide each year, resulting in roughly 11 million deaths, with about 1.32 million of these deaths directly linked... Read more

Pathology

view channel
Image: The PAXgene Urine Liquid Biopsy Set is the first standardized preanalytical workflow that stabilizes cell-free DNA in urine for subsequent analysis (Photo courtesy of PreAnalytiX)

Liquid Biopsy Solution Enables Non-Invasive Sample Collection and Direct Cell-Free DNA Stabilization from Urine

Urine cell-free DNA (cfDNA) presents significant potential for research and future clinical applications. It facilitates the measurement and analysis of cfDNA fragments, detection of genetic alterations,... Read more

Industry

view channel
Image: International expert meeting for trends and innovations in laboratory medicine - the MEDICA LABMED FORUM at MEDICA (Photo courtesy of Constanze Tillmann/Messe Düsseldorf)

MEDICA LABMED FORUM 2024: International Experts Meet to Discuss Trending Topics in Laboratory Medicine

At MEDICA (Düsseldorf, Germany), the world’s premier trade fair for the healthcare industry and medical technology sector, this year’s event (November 11–14) will focus on the most exciting medical advancements.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.